Fundraising Fox

Impact Biosystems, Inc.

Boston, US · Founded 2018 · Delaware corporation · 3 known investors

Boston-based health technology company developing biofeedback devices and recovery technology for fitness and wellness.

Also known as Impact Biosystems

Founders & leadership

IH
Ian HunterNamed on SEC filing
BH
Bridget Hunter-JonesNamed on SEC filing
SV
Sonny VuNamed on SEC filing

Board

IKIsaiah Kacyvenski
Isaiah Kacyvenskiin𝕏Board directorCo-Founder, Managing Partner at Will Ventures

Investors · 3

Also in the syndicate · 2

NextView VenturesleadUnion Labs

Reported raises · per SEC filings

Form D private placements

$6.5M disclosed across 1 of 2 rounds · 2021

$6.5MraisedApr 2021 · 12 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ian HunterDirector
  • Isaiah KacyvenskiDirector
  • Bridget Hunter-JonesExecutive Officer, Director
  • Sonny VuExecutive Officer, Director
Offering amount
$6.5M
Amount sold
$6.5M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Company profile

researched Aug 2026

Impact Biosystems, Inc. is a Boston, Massachusetts health technology company categorized under healthcare IT, with sub-industry classifications spanning healthcare IT, web applications, medical software and customer relationship management. The company develops biofeedback devices that monitor physiological metrics and translate them into data-driven insights, supporting personalized training regimens and health tracking for end users.

Its product approach pairs hardware devices with an accompanying application that delivers real-time feedback, analytics and personalized coaching. Following its seed financing, the company stated that proceeds would be applied to the development of active recovery technology and to designing additional products.

Business model

The company sells biofeedback devices directly to consumers, typically bundled with a subscription to an application that extends device functionality. Recurring subscription fees for premium features, analytics and personalized coaching complement one-time hardware sales, and pricing is structured in tiers across consumer segments. Strategic partnerships with fitness and wellness organizations support distribution.

Combination of one-time device sales and recurring subscription revenue for app-based premium features, analytics and coaching, using a tiered pricing structure.

Traction

Raised $4.5 million in seed funding in April 2021 from a syndicate including NextView Ventures, Will Ventures, Union Labs, SOSV and HAX.

Latest developments

The company indicated it would use its seed capital to develop active recovery technology, design new products and expand into additional geographic regions, particularly Europe.

Full profile — market position, technology, go-to-market, geography

Market position

Positioned as an angel- and seed-stage health technology venture within the consumer health and wellness device segment.

Technology

Biofeedback hardware that captures physiological metrics, coupled with software that analyzes the collected data to generate real-time feedback, progress tracking and personalized training and recovery guidance.

Go-to-market

Primarily direct-to-consumer sales of devices with attached app subscriptions, supported by partnerships with fitness and wellness organizations.

Fitness enthusiasts, rehabilitation centers and corporate wellness programs.

Geography

Headquartered in Boston, Massachusetts, United States, targeting North American and European markets, with stated plans to increase its European presence by 2023.

Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.

Key figures

latest reported
Company stageJan 2021Angel & Seed

Company-reported or press-reported figures, each dated to when it was claimed — not independently audited.

Timeline · 2

launches, deals, and filings
Jan 2023
Stated plan to expand footprint in Europe

As part of its growth strategy the company targeted increasing its presence in European markets by 2023.

source ↗

Apr 2021
Seed round of $4.5M co-led by NextView Ventures and Will Ventures

Impact Biosystems raised $4.5 million in seed funding co-led by NextView Ventures and Will Ventures, with participation from Union Labs, SOSV and HAX; proceeds earmarked for development of active recovery technology.

$4.5M source ↗

Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.

Legal entities · 1

corporate structure
Impact Biosystems, Inc.Delaware

Research sources · 1

primary sources listed

1 public sources were cited for this profile; the first-party ones are listed here.

Frequently asked questions

What does Impact Biosystems, Inc. do?
Boston-based health technology company developing biofeedback devices and recovery technology for fitness and wellness.
Who are Impact Biosystems, Inc.'s investors?
Impact Biosystems, Inc.'s investors include Will Ventures.
How much funding has Impact Biosystems, Inc. raised?
Impact Biosystems, Inc. has disclosed $6.5M raised across 1 of its 2 known rounds.
Where is Impact Biosystems, Inc. headquartered?
Impact Biosystems, Inc. is headquartered in Boston, US.